Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus

被引:37
作者
Howe, RA [1 ]
Wootton, M
Walsh, TR
Bennett, PM
MacGowan, AP
机构
[1] Southmead Hlth Serv NHS Trust, Bristol Ctr Antimicrobial Res & Evaluat, Bristol BS10 5NB, Avon, England
[2] Univ Bristol, Southmead Hosp, Dept Microbiol, Bristol BS10 5NB, Avon, England
[3] Univ Bristol, Dept Pathol & Microbiol, Sch Med Sci, Bristol BS8 1TD, Avon, England
关键词
D O I
10.1093/jac/44.5.675
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Isolates of Staphylococcus aureus resistant to vancomycin have been reported but appear to be extremely rare. However, isolates displaying hetero-resistance to vancomycin (hVRSA) are reportedly common in parts of Japan (9.3% of MRSA isolated from a group of university hospitals). We have investigated the reliability of the proposed method for detection of hetero-resistant isolates and the ability of clinical S. aureus isolates to express vancomycin resistance. The original method for identification of hVRSA was found to have poor reproducibility and may select for, rather than detect, vancomycin resistance. There appears to be a spectrum of heterogeneity in the expression of resistance to vancomycin among S. aureus. Until there is a clearer understanding of the mechanism and control of vancomycin resistance in S. aureus, and reliable tests are devised, the clinical relevance of different degrees of hetero-resistance cannot be assessed.
引用
收藏
页码:675 / 678
页数:4
相关论文
共 10 条
[1]  
*BRIT SOC ANT CHEM, 1991, GUID SENS TEST REP W
[2]  
*CDCP MMWR, 1997, STAPH AUR RED SUSC V, V46, P765
[3]   CHARACTERIZATION OF STAPHYLOCOCCUS-AUREUS ISOLATES WITH DECREASED SUSCEPTIBILITY TO VANCOMYCIN AND TEICOPLANIN - ISOLATION AND PURIFICATION OF A CONSTITUTIVELY PRODUCED PROTEIN ASSOCIATED WITH DECREASED SUSCEPTIBILITY [J].
DAUM, RS ;
GUPTA, S ;
SABBAGH, R ;
MILEWSKI, WM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) :1066-1072
[4]   BEHAVIOUR INVITRO OF SOME NEW ANTISTAPHYLOCOCCAL ANTIBIOTICS [J].
GARROD, LP ;
WATERWORTH, PM .
BMJ-BRITISH MEDICAL JOURNAL, 1956, 2 (JUL14) :61-65
[5]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[6]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[7]  
Howe RA, 1998, LANCET, V351, P602, DOI 10.1016/S0140-6736(05)78597-4
[8]  
National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE
[9]   First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital [J].
Ploy, MC ;
Grélaud, C ;
Martin, C ;
de Lumley, L ;
Denis, F .
LANCET, 1998, 351 (9110) :1212-1212
[10]   Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus [J].
Sieradzki, K ;
Tomasz, A .
JOURNAL OF BACTERIOLOGY, 1997, 179 (08) :2557-2566